Reduced monthly costs for uninsured patients still amount to around $500. That can put the drugs out of reach for many.

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

The pharmaceutical industry is criticizing the Trump administration’s plan for carrying out a critical round of Biden-era ...

The pharmaceutical industry is criticizing the Trump administration’s plan for carrying out a critical round of Medicare drug ...

The next round of Medicare's historic drug price negotiations could save billions for seniors taking medications like Ozempic ...

The sweeping One Big Beautiful Bill Act, signed into federal law July 4, amended CMS’ drug price negotiations authority that could absolve nearly $5 billion in projected savings, according to the ...

Mehmet Oz recently took the reins as the new head of the Centers for Medicare and Medicaid Services, which oversees health ...

Relief is coming for more than 5 million Medicare beneficiaries who rely on expensive prescription medications.

President Trump is attempting to reshape America’s biotech industry with two primary objectives. He wants more medicines to ...